Cleerly ISCHEMIA vs HealthCCSng

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Cleerly ISCHEMIA
by Cleerly
VS
HealthCCSng
by Nano-X AI

AI Verdict

Cleerly ISCHEMIA provides a detailed, non-invasive assessment of coronary artery ischemia and plaque characteristics from CCTA scans, aiding in treatment planning. HealthCCSng, conversely, analyzes routine CT scans to quantify coronary artery calcification, primarily for risk stratification of coronary artery disease. While both address heart health, Cleerly ISCHEMIA focuses on functional ischemia and detailed plaque analysis, whereas HealthCCSng focuses on calcification as a risk marker.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if you require a comprehensive, non-invasive assessment of coronary artery ischemia and detailed plaque characteristics from CCTA scans. This tool is ideal for physicians needing vessel-level ischemia likelihood, non-invasive FFR estimation, and precise plaque characterization to guide personalized diagnosis and treatment planning for heart disease.

View Cleerly ISCHEMIA →

Choose HealthCCSng if…

Choose HealthCCSng if your primary objective is to efficiently screen for coronary artery disease risk by automatically detecting and quantifying coronary artery calcification from routine, non-contrast CT scans. This solution is best suited for identifying patients at risk and categorizing their CAC burden without the need for specialized cardiac imaging, integrating seamlessly into existing PACS and EMR workflows.

View HealthCCSng →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Cleerly ISCHEMIA HealthCCSng
Pricing Contact for details Not publicly available
Deployment Web-based platform; data transfer via Cleerly Proxy (VPN or virtual appliance) Cloud-based, integrates with PACS and EMR systems
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

HealthCCSng

HealthCCSng emphasizes an automated workflow for results without human intervention and seamless integration with existing PACS and EMR systems, which streamlines the process for radiologists. It also offers customizable CAC category configuration, enhancing its flexibility for different clinical needs within routine CT scan analysis.

Clinical Value

Cleerly ISCHEMIA

Cleerly ISCHEMIA offers a more comprehensive assessment of coronary artery disease, including non-invasive fractional flow reserve (FFR) estimation and detailed coronary plaque characterization, which provides deeper clinical insights beyond just calcification. It has been clinically validated against invasive FFR and is billable under a Category I CPTu00ae Code, indicating a recognized and established clinical utility.

Pricing & Value

Cleerly ISCHEMIA

While both tools have opaque pricing, Cleerly ISCHEMIA has achieved a Category I CPTu00ae Code (75580) for non-invasive FFR estimation, which generally signifies a more established and favorable reimbursement pathway. This established reimbursement for a more advanced diagnostic tool suggests a higher potential for value realization for providers.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, and integration capabilities with existing healthcare IT infrastructure. Tool A explicitly states a Business Associate Agreement (BAA) is present, while Tool B emphasizes seamless integration with PACS and EMR for routine scans, making both highly adaptable for enterprise deployment.

Innovation

Cleerly ISCHEMIA

Cleerly ISCHEMIA is more innovative by providing a comprehensive assessment including non-invasive FFR estimation and detailed plaque characterization, moving beyond anatomical stenosis to functional significance. Its FDA Breakthrough Device Designation for its CAD Staging System further highlights its novel approach to CAD assessment.

Support & Docs

Cleerly ISCHEMIA

Cleerly provides a dedicated and comprehensive support section on its website, explicitly mentioning a commitment to customer success, timely assistance, and a range of resources like billing guidelines, patient education, and FAQs. For HealthCCSng, while clinical publications are mentioned, a clear and extensive support and documentation structure is not explicitly evident from the available information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Cleerly ISCHEMIA HealthCCSng
Tool Name Cleerly ISCHEMIA HealthCCSng
Company Cleerly Nano-X AI
Primary Analysis Input CCTA scans Routine CT scans (non-contrast, non-ECG gated chest CT scans)
Key Detection/Quantification Likelihood of coronary artery ischemia at a vessel level, non-invasive fractional flow reserve (FFR) estimation, coronary plaque characterization, stenosis severity assessment Coronary artery calcification (CAC) detection and quantification, numerical calcium score, categorization into 'zero', 'low', 'moderate', and 'severe' CAC categories
Integration Capabilities Integration with PowerScribe via API Integrates with PACS and EMR systems

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and HealthCCSng.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Cleerly ISCHEMIA (Tool A) is designed to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding in personalized diagnosis and treatment planning for heart disease. HealthCCSng (Tool B) focuses on automatically detecting and quantifying coronary artery calcification (CAC) from routine CT scans to identify patients at risk of coronary artery disease.
Cleerly ISCHEMIA (Tool A) analyzes CCTA (Coronary CT Angiography) scans. HealthCCSng (Tool B) analyzes routine non-contrast, non-ECG gated chest CT scans.
Cleerly ISCHEMIA offers AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization (volume, type, location), stenosis severity assessment, and 3D digital models. HealthCCSng provides automatic detection and quantification of CAC, categorizes studies into 'zero', 'low', 'moderate', and 'severe' CAC categories, and generates a numerical calcium score with visualization of calcified plaques.
Cleerly ISCHEMIA is a web-based platform with data transfer via Cleerly Proxy (VPN or virtual appliance) and integrates with PowerScribe via API. HealthCCSng is cloud-based and integrates seamlessly with PACS and EMR systems, offering an automated workflow for results without human intervention.
Yes, Cleerly ISCHEMIA (Tool A) offers non-invasive fractional flow reserve (FFR) estimation as one of its key features. HealthCCSng (Tool B) does not list FFR estimation among its features.
Yes, HealthCCSng (Tool B) is specifically designed to analyze non-contrast, non-ECG gated chest CT scans to automatically detect and quantify coronary artery calcification, identifying patients at risk of coronary artery disease. Cleerly ISCHEMIA (Tool A) requires CCTA scans.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or HealthCCSng

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

AI Tool Finder
AI-powered search. Results may not be comprehensive.